Technical / White Paper

NXT LVL Clinical Trials. Direct-to-Patient: Your Top 10 Q&A.

12 SEP 2016 Monday

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by World Courier, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Take your clinical trials to the next level. The direct-to-patient (DtP) model solves two of the largest issues plaguing clinical trials: patient recruitment and retention. This article answers the top 10 questions asked about DtP.

Download the Q&A to find answers to the following and more:

What are the major differences between DtP and traditional clinical trials?
How does a DtP model benefit patients?
How does a DtP model benefit trial sponsors?
What are the challenges and subsequent risks?

Latest content from World Courier

Content provided by World Courier

Risk mitigation: mission critical

Pharmaceutical manufacturers need to understand and mitigate the risk in supply chain logistics. World Courier explore five rising trends impacting security of a product in transport.